Synthekine
Synthekine is a clinical-stage biotechnology company discovering, developing, and commercializing the next generation of selective cytokine therapeutics. The company believes cytokine therapeutics engineered to be selective can fundamentally change the treatment paradigm for cancer and inflammatory disease. Synthekine's engineering platforms (including its surrogate/partial agonist and orthogonal cytokine-receptor approaches) are used to design cytokines and cytokine-based cell therapies with improved selectivity and tolerability. Backed by Canaan Partners and added to the API Evangelist network as a company profile; Synthekine is a therapeutics developer and publishes no public developer API surface at this time.
Synthekine is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Therapeutics, Cytokines, and Cell Therapy.
Synthekine’s developer surface includes engineering blog and 4 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Commercial 1
Pricing, plans, and the legal terms of use
Company 3
The organization behind the API